The present disclosure discloses and describes a vapocoolant dispenser. Specifically, the dispenser comprises a housing and container of vapocoolant, the dispenser configured to receive a sterilizable dose of high energy radiation and to provide a sterile, hermetically sealed vapocoolant dispenser.

The present disclosure discloses and describes a vapocoolant dispenser. Specifically, the dispenser comprises a housing and container of vapocoolant, the dispenser configured to receive a sterilizable dose of high energy radiation and to provide a sterile, hermetically sealed vapocoolant dispenser.

The present disclosure discloses and describes a vapocoolant dispenser. Specifically, the dispenser comprises a housing and container of vapocoolant, the dispenser configured to receive a sterilizable dose of high energy radiation and to provide a sterile, hermetically sealed vapocoolant dispenser.

A device (100) for alleviating itching is described. The device (100) includes a body (102) and a plurality of convex protrusions (106) being mounted on the body. In use, the plurality of convex protrusions (106) provides a plurality of contact points on a user's skin.

The invention preferably relates to a device for hyperthermal treatment of itching and/or herpes diseases comprising a control device on which at least two treatment programs are stored and an interface for a selection of one of the at least two treatment programs by means of a mobile device, so that after actuation of an operating element the control device heats a treatment surface according to the selected treatment program to a treatment temperature between 40°-65° C. and holds the treatment temperature for a treatment duration between 1 and 12 seconds.

The invention relates to a device for hyperthermic treatment of itching, for example following insect bites, wherein during the treatment a treatment surface is regulated at a temperature of preferably between 42° C. and 56° C. for a period of 2 sec to 12 sec and a hardware-implemented temperature monitor limits the maximum temperature of the treatment surface and a safety fuse shuts off the device in the case of a short-circuit or uncontrolled continuous heating.

The present disclosure discloses and describes a vapocoolant dispenser. Specifically, the dispenser comprises a housing and container of vapocoolant, the dispenser configured to receive a sterilizable dose of high energy radiation and to provide a sterile, hermetically sealed vapocoolant dispenser.

The present disclosure discloses and describes a vapocoolant dispenser. Specifically, the dispenser comprises a housing and container of vapocoolant, the dispenser configured to receive a sterilizable dose of high energy radiation and to provide a sterile, hermetically sealed vapocoolant dispenser.

The invention relates a device for the hyperthermal treatment of a herpes disease on a skin, preferably a lip, wherein a control device is configured to regulate a treatment surface on an outer side facing the skin by heating at least one heating element in a heating phase to a contact temperature of 43-47° C. during a contact of the treatment surface with the skin, preferably the lip, and to maintain the contact temperature in a treatment phase for a time period between 1 and 10 seconds.

The invention relates to a device for treating itching and/or herpes disease on a skin, wherein a control device is configured to regulate a treatment surface on an outer side facing the skin by heating at least one heating element in a heating phase to a contact temperature during a contact of the treatment surface with the skin and to maintain the temperature in a treatment phase, and wherein the device comprises at least one contact sensor.